tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kostas Biliouris, 134 are a BUY (82.21%), 29 are a HOLD (17.79%).
Analyst Kostas Biliouris, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 34.24% that have a potential upside of 45.1% achieved within 95 days.
Kostas Biliouris’s has documented 318 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals at 31-Jul-2026.
Analyst best performing recommendations are on BEAM (BEAM THERAPEUTICS).
The best stock recommendation documented was for BEAM (BEAM THERAPEUTICS) at 7/18/2022. The price target of $61 was fulfilled within 1 day with a profit of $2.99 (5.15%) receiving and performance score of 51.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Mar-2020
$28
$3.1 (12.45%)
$65
Buy Since 22-Jul-2024
$80
$55.1 (221.29%)
$80
2 months 5 days ago
(24-Aug-2026)
0/20 (0%)
$48.97 (157.82%)
Buy Since 27-Mar-2025
$47
$22.1 (88.76%)
$47
3 months 22 days ago
(07-Jul-2026)
0/3 (0%)
$10.12 (27.44%)
Buy Since 13-Dec-2022
$68
$33.19 (95.35%)
$56
7 months 3 days ago
(26-Mar-2026)
0/3 (0%)
$44.38 (187.89%)
Buy Since 06-Nov-2022
$47
$22.1 (88.76%)
$77
7 months 5 days ago
(24-Mar-2026)
0/4 (0%)
$23.88 (103.29%)
Which stock is Kostas Biliouris most bullish on?
What Year was the first public recommendation made by Kostas Biliouris?
